Parisi Gray Wealth Management Gilead Sciences, Inc. Transaction History

Parisi Gray Wealth Management

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 16, 2021	SELL	$67.69 - $73.03 $65,659 - $70,839	-970 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$63.47 - $69.35 $61,565 - $67,269	970 New	970 $67,000
Q2 2019 Jul 19, 2019	SELL	$61.87 - $69.38 $70,222 - $78,746	-1,135 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$62.53 - $70.05 $4,939 - $5,533	-79 Reduced 6.51%	1,135 $74,000
Q4 2018 Feb 12, 2019	BUY	$60.54 - $79.0 $4,782 - $6,241	79 Added 6.96%	1,214 $75,000
Q2 2018 Aug 13, 2018	SELL	$64.88 - $75.68 $2,270 - $2,648	-35 Reduced 2.99%	1,135 $85,000
Q4 2017 Feb 13, 2018	BUY	$71.15 - $83.52 $83,245 - $97,718	1,170	1,170 $87,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Parisi Gray Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Parisi Gray Wealth Management with notifications on news.